Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018, Synchrony Bio is a venture capital firm located in Saint Louis, Missouri. The firm specializes in early-stage investments in biomedical and life science ventures, particularly focusing on the medical device and diagnostics sectors. Synchrony Bio was established with the belief that seasoned talent is crucial for achieving superior returns in seed-stage investments. The firm operates across multiple U.S. regions, including the East Coast (New York City, Boston, Philadelphia, Washington D.C., Atlanta, North Carolina), the Midwest (St. Louis, Minneapolis, Michigan), and the West Coast (Seattle, Bay Area, Southern California). Additionally, Synchrony Bio has international operations in Ireland, Toronto, and Australia.
With a team of managing directors boasting over 70 years of combined experience in biomedical and life science startups, Synchrony Bio aims to align industry expertise with investment capital to enhance the efficiency of venture development. The firm is committed to addressing unmet needs in healthcare through rigorous due diligence and strategic partnerships. Their approach emphasizes the application of late-stage resources to early-stage investments, which helps mitigate risk and accelerate timelines for portfolio companies.
Synchrony Bio primarily invests in seed-stage biomedical and life science ventures, with a particular emphasis on medical devices and diagnostics. Their investment strategy is built on three key pillars: leveraging seasoned talent, providing staged investment capital, and enhancing process efficiencies. The firm seeks to identify unique technologies that can significantly impact healthcare, particularly those that address unmet needs. Synchrony Bio believes that aligning industry expertise with investment capital is essential for maximizing the impact of their investments.
The firm’s focus on early-stage investments allows them to engage deeply with portfolio companies, providing not just capital but also strategic guidance and industry connections. Synchrony Bio's investment criteria include a strong emphasis on the founding team's experience and the potential for technological innovation within the healthcare sector. Their approach is designed to mitigate risks associated with early-stage investing while amplifying the value of their portfolio companies.
Managing Directors: The team at Synchrony Bio comprises managing directors with over 70 years of combined experience in biomedical and life science startups, as well as large industry roles. Specific names and backgrounds were not disclosed in the available data, but their collective expertise spans various aspects of venture capital and industry leadership.
Startups interested in pitching to Synchrony Bio should send their proposals via email to info@synchronybio.com. The pitch deck should include a comprehensive overview of the business, the technology being developed, and the backgrounds of the founding team. It is advisable to clearly outline the market opportunity and how the startup plans to address unmet needs in healthcare.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review of the pitch.
What are Synchrony Bio's investment criteria?
Synchrony Bio focuses on seed-stage investments in biomedical and life science ventures, particularly in the medical device and diagnostics sectors. They prioritize companies that demonstrate unique technologies capable of addressing unmet healthcare needs.
How can startups apply or pitch to Synchrony Bio?
Startups can pitch to Synchrony Bio by sending an email to info@synchronybio.com. It is recommended to include a detailed overview of the business model, technology, and the founding team's background in the pitch.
What makes Synchrony Bio different from other venture capital firms?
Synchrony Bio differentiates itself by aligning seasoned industry talent with investment capital, which enhances the efficiency of venture development. Their model applies late-stage resources to early-stage investments, helping to mitigate risks and accelerate timelines.
What is Synchrony Bio's geographic scope?
The firm primarily invests in the United States but also has international operations in Ireland, Toronto, and Australia. Their focus is on regions with strong biomedical and life science ecosystems.
What is the typical check size for investments?
While specific check sizes are not disclosed, Synchrony Bio focuses on seed-stage investments, which typically range from hundreds of thousands to a few million dollars, depending on the venture's needs and potential.
What kind of post-investment involvement does Synchrony Bio have?
Synchrony Bio actively engages with its portfolio companies, providing strategic guidance, industry connections, and resources to help accelerate growth and navigate challenges in the biomedical and life science sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.